Comerica (CMA)
(Delayed Data from NYSE)
$55.56 USD
-0.21 (-0.38%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $55.56 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value F Growth F Momentum D VGM
Price, Consensus and EPS Surprise
CMA 55.56 -0.21(-0.38%)
Will CMA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CMA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CMA
Analysts Estimate Comerica Incorporated (CMA) to Report a Decline in Earnings: What to Look Out for
JPMorgan Chase & Co. (JPM) Tops Q2 Earnings and Revenue Estimates
CMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Comerica (CMA) Aided by NII & Loan Growth Amid Cost Woes
3 S&P 500 Banks With Solid Dividend Yield to Keep an Eye On
Comerica (CMA), OCC Enters Agreement Over Compliance Issues
Other News for CMA
US wholesale inflation picked up in June in sign that some price pressures remain elevated
Noteworthy Friday Option Activity: CMA, SNOW, SQ
Comerica price target lowered by $5 at JPMorgan, here's why
Comerica: High Dividend Yield Is Not Enough To Buy
Medtronic reaffirms guidance as HP taps CFO